Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA
US5821087A · kind A · utility
16Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1996 |
| Grant date | Oct 13, 1998 |
| Priority date | — |
| Expiry date | Sep 11, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/918
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a recombinant human papillomavirus type 11 L1 protein encoded by a synthetic DNA molecule and methods of making and using the protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.